Browsing Tag
Covaxin
Now, Precautionary Covid Vaccine Available At 3 City Hosps, 21 Chcs, Health News, ET…
Prayagraj: With an objective to administer a precautionary dose to all eligible recipients, officials of the health department have ensured adequate stock of Covishield booster dose at three…
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™…
Study met both co-primary endpoints with robust immune responses COVAXIN™ was found to be well-tolerated in vaccine-naïve individuals and in individuals previously vaccinated with mRNA…
Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences
MALVERN, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing…
India Hits 200 Crore Vaccination Milestone
India achieved the historic milestone of the 200 crore mark in Covid-19 vaccination. The milestone was reached after 18 months when the nation began the mass vaccination on January 16, 2021.…
Covid-19 Top Updates: India records 18,840 fresh infections, 43 deaths; NTAGI panel…
India witnessed 18,840 new coronavirus cases in the country in the last 24 hours, the data released by the union health ministry suggests. The death toll has risen to 5,25,386 with 43 new…
Covaxin Covid-19 vaccine reports higher efficacy in paediatric population
Bharat Biotech’s Covid-19 vaccine — Covaxin — has reported higher neutralising antibodies in children and on an average, it was 1.7 times higher than in adults. The vaccine was…
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat…
Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group…